Intelerad acquires LUMEDX, expands cardiovascular expertise

By Leila Hawkins
The acquisition expands Intelerad’s ability to provide enterprise imaging and insights, growing its cardiovascular expertise...

Intelerad, a medical imaging software provider, has acquired LUMEDX, a US-based company that specialises in cardiovascular analytics. 

The deal follows Intelerad’s December acquisition of cardiovascular imaging provider Digisonics Inc, and marks its third deal in just six months, giving Intelerad a strong portfolio of cardiovascular solutions. 

In 2020, Intelerad also acquired Radius, a private cloud platform provider, and was awarded Best in KLAS Recognition for PACS Asia/Oceania in the 2020 Best in KLAS Global Report.

In a press release the company stated that as a result of the COVID-19 pandemic cardiovascular procedures have declined significantly; however they expect this to rebound in 2021. Furthermore, Intelerad say that delivering a comprehensive enterprise imaging platform including robust cardiovascular offerings is critical as hospitals, health systems and imaging centers seek to consolidate their imaging requirements on a single-vendor platform.

“Healthcare as we know it has forever changed, and more than ever, providers need automated solutions that allow them to focus on what they do best – treating patients and providing improved patient care” said Mike Lipps, CEO of Intelerad. 

“Bringing LUMEDX into the Intelerad portfolio further enables our team to provide customers with the most comprehensive enterprise imaging platform in the industry.”

Intelerad was founded in 1999 with headquarters in Montreal. Today the company serves over 300 healthcare organisations around the world including hospitals, radiology groups, imaging centers and other clinics, with locations in the UK, Australia, the US and Canada. 

Meanwhile LUMEDX has been operating for more than 25 years, providing health registry software for cardiovascular medicine. This includes a partnership with Microsoft, offering HealthView Analytics (HVA) which uses the Azure Data Factory infrastructure to extract insights using clinical and financial data from enterprise systems. 

“Over the last two and a half decades, LUMEDX has been laser-focused on our vision of delivering an end-to-end suite of software and services that improves continuity of care” Allyn McAuley, Ph.D., Chief Executive Officer and Co-Founder of LUMEDX said. 

“Joining forces with Intelerad enables us to further achieve this goal, as well as provide customers increased automation that results in greater clinical efficiency and improved patient care.”

Share

Featured Articles

Philips Future Health Index Report: AI to Cut Waiting Times

Healthcare technology leader Philips says virtual care and AI is turning in an effort to cope with demand in its Future Health Index Report 2024

HCLTech and Olympus Advance AI into the Healthcare Industry

Giants HCLTech and Olympus Corporation, have developed their partnership to utilise technology and AI to transform the healthcare industry.

Cancer Vaccines Breakthrough a Glimpse of Healthcare Future

As the UK's NHS becomes the first healthcare provider to launch a cancer vaccine testing programme, we explore this groundbreaking oncological treatment

Change Healthcare Cyberattack Fallout Continues

Health Insurance & Finance

McKinsey: National E-health Initiatives on the Rise

Technology & AI

Edwards Lifesciences: a Profile of the Heart Tech Specialist

Medical Devices & Pharma